






nlvpartners | Funding the healthcare revolution.
































































 



 










NEW LEAF VENTURE PARTNERS
 
 
 
 




 
Funding the healthcare revolution
 

 
 
 
 
 
 
 

 













New Leaf Venture Partners LLC: Company Profile - Bloomberg



































































  









Feedback


































new leaf venture partners llc
Private Company









Company Profile
Sector: Financials
Industry: Asset Management
Sub-Industry: Private Equity
New Leaf Venture Partners, L.L.C. operates as a venture capital firm. The Company invests in biopharmaceutical, information convergence, medical devices, and biological research companies. New Leaf Venture Partners serves customers in the States of New York and California.




Corporate Information
Address:

Times Square Tower
7 Times Square, Suite 3502
New York, NY 10036
United States


Phone:
1-646-871-6400


Fax:
1-646-871-6450


Web url:
www.nlvpartners.com























From The Web











Key Executives


Ronald M Hunt "Ron"


Managing Director/Co-Founder




Jeani Delagardelle


Managing Director/Co-Founder




Vijay Lathi


Managing Director/Co-Founder




Liam Ratcliffe


Managing Director




James Niedel "Jim"


Venture Partner/Co-Founder




Jeffrey Ives "Jeff"


Venture Partner




Isaac Manke


Partner:Public Equity




Craig Slutzkin


CFO/CAO




Dan Becker


Principal




Eric Kim


Vice President




Rebecca Luse


Vice President



Show More


Show Less






Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data




































New Leaf Venture Partners, L.L.C.: Private Company Information - Bloomberg










































  





















































































July 27, 2017 5:38 AM ET
Capital Markets

Company Overview of New Leaf Venture Partners, L.L.C.



Snapshot People




Company Overview
New Leaf Venture Partners, L.L.C. is a private equity and venture capital firm specializing in growth capital and PIPES transactions in incubation, seed, early, mid, and late venture, later stage investments in public and private companies. It prefers to invest in biopharmaceutical products, commercial stage medical devices, healthcare-related information technology, life science tools and services, pharmaceutical research and development, medical device research equipment, and variety of stages in molecular diagnostics, information convergence, healthcare biological research, and laboratory infrastructure technologies. Within biopharmaceuticals, the firm seeks to invest in drug development,...
New Leaf Venture Partners, L.L.C. is a private equity and venture capital firm specializing in growth capital and PIPES transactions in incubation, seed, early, mid, and late venture, later stage investments in public and private companies. It prefers to invest in biopharmaceutical products, commercial stage medical devices, healthcare-related information technology, life science tools and services, pharmaceutical research and development, medical device research equipment, and variety of stages in molecular diagnostics, information convergence, healthcare biological research, and laboratory infrastructure technologies. Within biopharmaceuticals, the firm seeks to invest in drug development, clinical trial design, and pharmaceutical markets. It prefers to invest between $5 million and $30 million in its portfolio companies. The firm typically seeks to take a board seat in its portfolio companies. New Leaf Venture Partners, L.L.C. was founded in 1993 and is based in New York, New York with an additional office at San Mateo, California.
Detailed Description


Times Square Tower7 Times SquareSuite 3502New York, NY 10036United StatesFounded in 1993



Phone: 646-871-6400

Fax: 646-871-6450

www.nlvpartners.com







Key Executives for New Leaf Venture Partners, L.L.C.




Dr. Philippe O. Chambon M.D., Ph.D.


      	Managing Director
      


Age: 58
        







Ms. Jeani Delagardelle


      	Managing Director
      








Mr. Craig L. Slutzkin CPA


      	Chief Financial Officer and Chief Administrative Officer
      








Mr. Ronald M. Hunt


      	Managing Director
      


Age: 52
        







Mr. Vijay K. Lathi


      	Managing Director
      


Age: 45
        




Compensation as of Fiscal Year 2017. 

New Leaf Venture Partners, L.L.C. Key Developments

New Leaf Venture Partners, L.L.C. Presents at 2016 BIO Investor Forum, Oct-19-2016 10:00 AM
Oct 10 16
New Leaf Venture Partners, L.L.C. Presents at 2016 BIO Investor Forum, Oct-19-2016 10:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Liam Ratcliffe, Managing Director.


Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target





Private Placement

			      June 1, 2017
			    
Neuronetics, Inc.



Private Placement

			      May 26, 2017
			    
Deciphera Pharmaceuticals, LLC



Private Placement

			      May 24, 2017
			    
Harpoon Therapeutics, Inc.





Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact New Leaf Venture Partners, L.L.C., please visit www.nlvpartners.com.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version












 






Liam Ratcliffe, Managing Director, New Leaf Venture Partners


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Liam Ratcliffe



Managing Director
at
New Leaf Venture Partners


Location: Greater New York City Area





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Liam Ratcliffe



Managing Director
at
New Leaf Venture Partners


Location: Greater New York City Area




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Liam Ratcliffe is a Managing Director at New Leaf Venture Partners, and concentrates on biopharmaceutical investing. Liam joined New Leaf in September 2008.  Liam previously served as Senior Vice President and Development Head for Pfizer Neuroscience, as well as Worldwide Head of Clinical Research and Development. Additional positions during his 12 years at Pfizer included Vice President of Exploratory Development for the Mid West region (based in Ann Arbor, MI), and Head of Experimental Medicine at Pfizer’s Sandwich, UK Laboratories. As Head of Neurosciences, Liam was responsible for the development of several successful late-stage projects and marketed products, including Lyrica, Chantix and Geodon. In previous roles, he gained extensive experience in early drug development and translational research across multiple therapeutic areas, including inflammation, pain, cardiovascular disease, infectious diseases and genito-urinary medicine.
Liam began his career in the pharmaceutical industry in a medical marketing role at Roche in South Africa. He received his M.D. degree and Ph.D. degree in immunology from the University of Cape Town and his M.B.A. degree from the University of Michigan. Liam completed his internal medicine training and fellowship in Immunology at Groote Schuur Hospital and associated teaching hospitals in Cape Town, South Africa.
Liam also serves on various industry panels, including the Leadership Counsel of the University of Michigan Life Sciences Institute, the Advisory Council of the Keck Graduate Institute, the Life Sciences Advisory Panel of Frankel Consulting and the Pfizer External Advisory Panel for Ophthalmology, the AstraZeneca External Advisory Panel for Research & Development Strategy and Anti-Infectives.



6

Companies in Career





N/A

Related Markets





4

Colleagues





4

Related Investments








Alias
N/A



Industry
Finance as a service




Tags
N/A




Topics of Influence












N/A







N/A



























Careers








Achievements








Investments








Related People






 Edit
View all 



Liam RatcliffeCareer (7)






May-2016




Aptinyx



Board Member







Oct-2015




Arvinas



Board Member







Sep-2015




Deciphera Pharmaceuticals



Board Member







Jun-2013




New Leaf Venture Partners



Managing Director












Neuronetics



Board Member







Sep-2008 to Jun-2013




New Leaf Venture Partners



General Partner








Competencies










 Edit
View all 



Liam RatcliffeEducation (3)






2006



University of Michigan - Stephen M. Ross School of Business









1994



University of Cape Town


Immunology






1987



University of Cape Town


Medicine









 Edit



Liam RatcliffeAchievements and Recognitions





Add Milestone


No milestones has been recorded for Liam Ratcliffe






 Edit



Liam RatcliffeLinks





Add Link


No links has been recorded for Liam Ratcliffe









Liam RatcliffeInvestments/Acquisitions





No investments has been recorded for Liam Ratcliffe






View all 



Liam RatcliffeInvestments Representing Others (4)









lead
Unum Therapeutics

Representing: New Leaf Venture Partners



Since Jun-2015


Series: B

Company status: PRIVATE








lead
Deciphera Pharmaceuticals

Representing: New Leaf Venture Partners



Since Sep-2015


Series: B, C

Company status: PRIVATE








lead
Aptinyx

Representing: New Leaf Venture Partners



Since May-2016


Series: A

Company status: PRIVATE








Arvinas

Representing: New Leaf Venture Partners



Since Oct-2015


Series: B

Company status: PRIVATE










Liam RatcliffeRelated People








Colleagues at New Leaf Venture Partners







Mike Dybbs

Partner
May-2009









Mike Dybbs

Principal
May-2009









Vijay Lathi

Managing Director
2005









Philippe Chambon

Founder and managing director
Jul-2005








View all 
Peers (3)







Jeani Delagardelle

Director of Business Operations of Roche Laboratories









Vijay Lathi

Managing Director of New Leaf Venture Partners









Philippe Chambon

Founder and managing director of New Leaf Venture Partners












View all 



Liam RatcliffeRecommended Market Profiles (8)








Telemedicine

10,000 or More employees
19 companies








Social Media Marketing (ChiefMartec.com)

5,000 - 10,000 employees
111 companies








Big Data Universe List of Lists

10,000 or More employees
533 companies








Aggregated Marketing Technology

10,000 or More employees
2650 companies








Shared Economy Landscape (Jeremiah Owyang)

10,000 or More employees
267 companies








Inside Sales Landscape

10,000 or More employees
650 companies





















        The Daily Startup: New Leaf Venture Partners Sprouts $200M Growth Fund - Venture Capital Dispatch - WSJ
    



















































































































DOW JONES, A NEWS CORP COMPANY








News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.

DOW JONES

Barron's
BigCharts
DJX
Dow Jones Newswires
Factiva
Financial News
Mansion Global
MarketWatch


Newsmart
NewsPlus
Private Markets
Risk & Compliance
WSJ.com
WSJ Pro
WSJ Conference
WSJ Video



NEWS CORP

Big Decisions
Business Spectator
Checkout51
Harper Collins
New York Post
PropTiger
REA


realtor.com
Storyful
The Australian
The Sun
The Times













Stoxx 600
▲

382.43
-0.08%



 


Nikkei
▲

20079.64
0.15%



 


U.S. 10 Yr
▲

-2/32 yield
2.296%



 


Crude Oil
▲

48.66
-0.18%



 


Euro
▲

1.1725
-0.08%



 


DJIA
▲

21711.01
0.45%



 











Subscribe Now
Sign In





The Wall Street Journal




Sections



                    My Journal
                    
                  





Home


World


U.S.


Politics


Economy


Business


Tech


Markets


Opinion


Arts


Life


Real Estate


Today's Paper


SHOW ALL SECTIONS
HIDE ALL SECTIONS




World Home


Africa
Asia
Canada
China
Europe
Latin America
Middle East


Economy


World Video




U.S. Home


Economy
Law
New York
Politics


Real Time Economics
Washington Wire


Journal Report
U.S. Video
What's News Podcast




Politics Home


Washington Wire


Politics Video
WSJ/NBC News Poll




Economy Home


Real Time Economics


Economic Forecasting Survey
Economy Video




Business Home


Management
Tech/WSJ.D


Aerospace & Defense
Autos & Transportation
Commercial Real Estate
Consumer Products
Energy
Entrepreneurship
Financial Services
Food & Services
Health Care
Hospitality
Law
Manufacturing
Media & Marketing
Natural Resources
Retail


CFO Journal
CIO Journal
CMO Today
Logistics Report
Risk & Compliance


Heard on the Street


Business Video
Journal Report
Business Podcast




Tech Home


CIO Journal


Geoffrey Fowler
Christopher Mims
Joanna Stern
Li Yuan


Billion Dollar Startup Club
Tech Video
Tech Podcast
Startup Stock Trader




Markets Home


Bonds
Commercial Real Estate
Commodities & Futures
Currencies
Deals
Financial Services
Funds
Stocks
Your Money


Heard on the Street
MoneyBeat
Wealth Adviser
Ahead of the Tape


CFO Journal
Journal Report
Market Data
Markets Video
Markets Podcast
MoneyBeat Podcast
Watching Your Wealth Podcast




Opinion Home


James Freeman
William A. Galston
Daniel Henninger
Holman W. Jenkins
William McGurn
Peggy Noonan
Mary Anastasia O'Grady
Jason Riley
Kimberley A. Strassel


Books
Film
Television
Theater
Art
Masterpiece Series
Music
Dance
Opera
Exhibition
Cultural Commentary


Editorials
Commentary
Letters to the Editor
The Weekend Interview
Potomac Watch Podcast
Foreign Edition Podcast
Opinion Video
Notable & Quotable
Best of the Web Newsletter
Morning Editorial Report Newsletter




Arts Home


Books
Film
Television
Theater
Art
Masterpiece Series


Arts Video
WSJ. Magazine




Life Home


Careers
Cars
Food & Drink
Health
Ideas
Real Estate
Science
Sports
Style & Fashion
Travel


Life Video
WSJ. Magazine
WSJ Puzzles
The Future of Everything




Real Estate Home


Commercial Real Estate
House of the Day
Mansion


Real Estate Video





HIDE ALL SECTIONS





Aim higher, reach further.

                Get the Wall Street Journal $12 for 12 weeks.
                Subscribe Now


Sign In


Reveal Navigation Options



Subscribe
Sign In





















                                Dyn Says Cyberattack Has Ended, Investigation Continues
                              











                                Visa Taps Blockchain for Cross-Border Payment Plan
                              











                                Airbnb Revises New York Rules Amid Possible Legislation
                              











                                Russian Hacker Suspected of LinkedIn Attack Indicted in U.S.
                              











                                FCC Reaches Settlement With T-Mobile Over Unlimited Plans
                              











                                Kabam Weighs Multiple Offers for Canada Studio
                              











                                Snapchat to Revamp Ad Sales Agreements With Publishers
                              











                                The Natural Side of A.I.
                              











                                Google Signs Up CBS for Planned Web TV Service
                              











                                IPO Hopeful Bloom Energy Enlisted Colin Powell for Tax-Credit Extension
                              











                                Cybersecurity: Peace of Mind Isn’t Priceless
                              











                                Google Pitches Survey Tool to Measure Effectiveness of Advertising, Branded Content
                              











                                Calling Tehran: Vodafone Leaps Into Iran With Internet-Service Deal
                              











                                Turns Out Belichick Is Not a Big Tablet Guy
                              











                                Nintendo Earnings: What to Watch
                              











                                ‘Grand Theft Auto’ Game Publisher Plans New Title
                              











                                Salesforce’s M&A Target List Excluded Twitter
                              













































 

                        Small
                      


 

                        Medium
                      


 

                        Large
                      








Save Article
Sign In to Save
Subscribe to WSJ
















Next Story >



Venture Capital Dispatch




The Daily Startup: New Leaf Venture Partners Sprouts $200M Growth Fund






                    Jun 22, 2015 10:19 am  ET
                  


Art by Mike Lucas
In this morning’s Web roundup, Sense.ly gets capital for its  “virtual nurse” product. Google Ventures backs an Oxford University fund.



                      To Read the Full Story
                    


                        Subscribe
                      

                        Sign In
                      











Previous
Dollar Shave Club Is Valued at $615 Million



Next
Instacart to Convert Some Contract Workers to Employee Status

 
















Most Popular Videos









Is Kushner's Statement a Turning Point for Trump Team?









USS Thunderbolt Fires Warning Shots at Iranian Vessel in Gulf









China's New Nationalists









Film Clip: 'Detroit'









Lego Boost: The Ultimate Kid Review






Most Popular Articles








How Jony Ive Masterminded Apple’s New Headquarters








A Catholic School’s Dilemma: How to Spend Its Snap IPO Millions








Working From Home? The Boss Wants You Back in the Office








President to Bar Transgender People From the Military 








Opinion: Trump’s Sessions Abuse



















              Popular on WSJ
            








Most Popular Videos









Is Kushner's Statement a Turning Point for Trump Team?









USS Thunderbolt Fires Warning Shots at Iranian Vessel in Gulf









China's New Nationalists









Film Clip: 'Detroit'









Lego Boost: The Ultimate Kid Review






Most Popular Articles








How Jony Ive Masterminded Apple’s New Headquarters








A Catholic School’s Dilemma: How to Spend Its Snap IPO Millions








Working From Home? The Boss Wants You Back in the Office








President to Bar Transgender People From the Military 








Opinion: Trump’s Sessions Abuse


















        
        
        
        
        
           
             
               
             
           
        
          
            
              
            
          
        
          
            
              
            
          
        
          
            
              
            
          
        
        
          
            
            
              
            
            
              Save Article
              Sign In to Save
              Subscribe to WSJ
            
          
        
           
             
               
             
           
           
             
               
             
           
        
        
        
        
          
          
            
              
            
            
              Text Size
          
              
              
                          

                Small
              
          
              
              
                          

                Medium
              
          
              
              
                          

                Large
              
            
          
          
          
          
          
          
          
          
          
          
          
            
              
                
                  
                    
                      
                    
                    Print
                  
                
                
                  
                    
                      
                    
                    Facebook
                  
                
                
                  
                    
                      
                    
                    Twitter
                  
                
                
                  
                    
                      
                    
                    WhatsApp
                  
                
          
                
                  
                    
                      
                    
                    SMS
                  
                
          
          
                
                  
                    
                      
                    
                    Copy Link
                  
                
          
              
          
              
                
              
          
            
          
          
          
        
        
































﻿





Tioga Pharmaceuticals









TEAM
DRUG DEVELOPMENT
INVESTORS
PRESS
CAREERS
CONTACT





Investors

 




	
	Forward Ventures, founded in 1993, is a leading life-science venture capital 
	firm located in San Diego. Forward Ventures has a team of investment 
	professionals with extensive experience in entrepreneurship, venture capital 
	and operations.

	The firm has invested in over 50 companies since it was founded in 1993 and 
	currently has more than $500 million in capital under management.





	
	New Leaf Venture Partners is a leader in healthcare technology venture 
	investing. The investment professionals at New Leaf Venture Partners bring a 
	unique blend of technological, clinical, and operational experience to our 
	investments. These professionals work closely with entrepreneurs to help 
	build successful portfolio companies. 

	New Leaf Venture Partners focuses primarily on later stage biopharmaceutical 
	products, early stage medical devices, and laboratory infrastructure 
	technologies.






	BB Biotech Ventures is a healthcare-dedicated venture capital fund, focused 
	on companies that develop and market drugs and medical devices.





	
	Genesys Capital is focused on building companies in the high-growth sectors 
	of healthcare and biotechnology. Through its expertise and network, Genesys 
	accelerates the development of commercially viable emerging companies that 
	represent promising life science investment opportunities. 






	Thomas, McNerney & Partners is a venture capital firm that invests in life 
	science and medical technology companies. Employing a multi-stage investment 
	approach, Thomas, McNerney & Partners has $600 million in assets under 
	management and provides seed and early stage funding to help entrepreneurs 
	launch companies, as well as growth capital to emerging companies for 
	furthering clinical development or for expansion of product 
	commercialization.



 


©Tioga Pharmaceuticals. All rights reserved.



